Bardoxolone methyl: A targeted antioxidant

Renal Failure

Volumn 33, Issue 10, 2011, Pages 1051-

  Gupta, Ankur ^a   Khaira, Ambar ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Moolchand Hospital   (India)

Author keywords

Antioxidant; Bardoxolone methyl; Chronic kidney disease; Diabetic nephropathy

Indexed keywords

BARDOXOLONE METHYL; CATALASE; GLUTATHIONE; HEME OXYGENASE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; TERPENOID DERIVATIVE; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT ACTIVITY; DIABETIC NEPHROPATHY; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTIOXIDANTS; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; OLEANOLIC ACID;

EID: 80054884435     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.618970     Document Type: Letter

References (6)

1. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008; 57:1446-1454.
2. Yoh K, Itoh K, Enomoto A, et al. Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int. 2001;60:1343-1353. (Pubitemid 32960028)
3. Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol. 2010;298:F662-F671.
4. Liby KT, Yore MM, Sporn MB. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer. 2007;7:357-369. (Pubitemid 46652485)
5. Pergola PE, Krauth M, Huff JW, et al. Effect of bardoxolone methyl on kidney function in patients with T2D and stage 3b-4 CKD. Am J Nephrol. 2011;33:469-476.
6. Sporn MB, Liby KT, Yore MM, Fu L, Lopchuk JM, Gribble GW. New synthetic triterpenoids: Potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J Nat Prod. 2011;74:537-545.